APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Preventive

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Asthma Preventive Industry Growth and Trends Forecast to 2032

20 December 2025109 pages

Choose your research edition.

Industry ResearchAsthma Preventive Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Preventive Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Asthma Preventive Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Preventive Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Preventive Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Asthma Preventive market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Preventive include Novartis, Merck, Roche, Pfizer, GSK, Amgen, Astrazeneca, Sumitomo Dainippon Pharma and Chiesi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Asthma Preventive market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Asthma Preventive market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Asthma Preventive market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Asthma Preventive.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Asthma Preventive market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Asthma Preventive Market by Company

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Astrazeneca

Sumitomo Dainippon Pharma

Chiesi

Boehringer Ingelheim

Biotest AG

Abbot

Asthma Preventive Segment by Type

Sodium Cromolyn

Prednisolone

Asthma Preventive Segment by Application

Children

Adult

Asthma Preventive Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Preventive market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Preventive and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Preventive.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Asthma Preventive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Sodium Cromolyn Table 2. Major Company of Prednisolone Table 3. Global Asthma Preventive Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Asthma Preventive Sales by Type (2021-2026) & (k units) Table 5. Global Asthma Preventive Sales Market Share in Volume by Type (2021-2026) Table 6. Global Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 7. Global Asthma Preventive Sales Market Share in Value by Type (2021-2026) Table 8. Global Asthma Preventive Price by Type (2021-2026) & (US$/unit) Table 9. Global Asthma Preventive Sales by Type (2027-2032) & (k units) Table 10. Global Asthma Preventive Sales Market Share in Volume by Type (2027-2032) Table 11. Global Asthma Preventive Sales by Type (2027-2032) & (US$ Million) Table 12. Global Asthma Preventive Sales Market Share in Value by Type (2027-2032) Table 13. Global Asthma Preventive Price by Type (2027-2032) & (US$/unit) Table 14. North America Asthma Preventive Sales by Type (2021-2026) & (k units) Table 15. North America Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Asthma Preventive Sales by Type (2021-2026) & (k units) Table 17. Europe Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Asthma Preventive Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Asthma Preventive Sales by Type (2021-2026) & (k units) Table 21. Latin America Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Asthma Preventive Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Asthma Preventive Sales by Type (2021-2026) & (US$ Million) Table 24. Asthma Preventive Industry Trends Table 25. Asthma Preventive Industry Drivers Table 26. Asthma Preventive Industry Opportunities and Challenges Table 27. Asthma Preventive Industry Restraints Table 28. Global Asthma Preventive Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Asthma Preventive Revenue Market Share by Company (2021-2026) Table 30. Global Asthma Preventive Sales by Company (2021-2026) & (k units) Table 31. Global Asthma Preventive Sales Share by Company (2021-2026) Table 32. Global Asthma Preventive Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Asthma Preventive Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Asthma Preventive Major Company Production Sites and Headquarters Table 35. Global Asthma Preventive Company, Product Type & Application Table 36. Global Asthma Preventive Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Asthma Preventive by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Asthma Preventive Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Asthma Preventive Sales by Region (2021-2026) & (k units) Table 41. Global Asthma Preventive Sales Market Share in Volume by Region (2021-2026) Table 42. Global Asthma Preventive Sales by Region (2021-2026) & (US$ Million) Table 43. Global Asthma Preventive Sales Market Share in Value by Region (2021-2026) Table 44. Global Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Asthma Preventive Sales by Region (2027-2032) & (k units) Table 46. Global Asthma Preventive Sales Market Share in Volume by Region (2027-2032) Table 47. Global Asthma Preventive Sales by Region (2027-2032) & (US$ Million) Table 48. Global Asthma Preventive Sales Market Share in Value by Region (2027-2032) Table 49. Global Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Asthma Preventive Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Asthma Preventive Sales by Application (2021-2026) & (k units) Table 52. Global Asthma Preventive Sales Market Share in Volume by Application (2021-2026) Table 53. Global Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 54. Global Asthma Preventive Sales Market Share in Value by Application (2021-2026) Table 55. Global Asthma Preventive Price by Application (2021-2026) & (US$/unit) Table 56. Global Asthma Preventive Sales by Application (2027-2032) & (k units) Table 57. Global Asthma Preventive Sales Market Share in Volume by Application (2027-2032) Table 58. Global Asthma Preventive Sales by Application (2027-2032) & (US$ Million) Table 59. Global Asthma Preventive Sales Market Share in Value by Application (2027-2032) Table 60. Global Asthma Preventive Price by Application (2027-2032) & (US$/unit) Table 61. North America Asthma Preventive Sales by Application (2021-2026) & (k units) Table 62. North America Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Asthma Preventive Sales by Application (2021-2026) & (k units) Table 64. Europe Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Asthma Preventive Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Asthma Preventive Sales by Application (2021-2026) & (k units) Table 68. Latin America Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Asthma Preventive Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Asthma Preventive Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Asthma Preventive Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck Asthma Preventive Product Portfolio Table 80. Merck Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Roche Asthma Preventive Product Portfolio Table 85. Roche Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Asthma Preventive Product Portfolio Table 90. Pfizer Recent Development Table 91. GSK Company Information Table 92. GSK Business Overview Table 93. GSK Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GSK Asthma Preventive Product Portfolio Table 95. GSK Recent Development Table 96. Amgen Company Information Table 97. Amgen Business Overview Table 98. Amgen Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Amgen Asthma Preventive Product Portfolio Table 100. Amgen Recent Development Table 101. Astrazeneca Company Information Table 102. Astrazeneca Business Overview Table 103. Astrazeneca Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Astrazeneca Asthma Preventive Product Portfolio Table 105. Astrazeneca Recent Development Table 106. Sumitomo Dainippon Pharma Company Information Table 107. Sumitomo Dainippon Pharma Business Overview Table 108. Sumitomo Dainippon Pharma Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio Table 110. Sumitomo Dainippon Pharma Recent Development Table 111. Chiesi Company Information Table 112. Chiesi Business Overview Table 113. Chiesi Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Chiesi Asthma Preventive Product Portfolio Table 115. Chiesi Recent Development Table 116. Boehringer Ingelheim Company Information Table 117. Boehringer Ingelheim Business Overview Table 118. Boehringer Ingelheim Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Boehringer Ingelheim Asthma Preventive Product Portfolio Table 120. Boehringer Ingelheim Recent Development Table 121. Biotest AG Company Information Table 122. Biotest AG Business Overview Table 123. Biotest AG Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Biotest AG Asthma Preventive Product Portfolio Table 125. Biotest AG Recent Development Table 126. Abbot Company Information Table 127. Abbot Business Overview Table 128. Abbot Asthma Preventive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Abbot Asthma Preventive Product Portfolio Table 130. Abbot Recent Development Table 131. North America Asthma Preventive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Asthma Preventive Sales by Country (2021-2026) & (k units) Table 133. North America Asthma Preventive Sales Market Share by Country (2021-2026) Table 134. North America Asthma Preventive Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Asthma Preventive Sales Market Share Forecast by Country (2027-2032) Table 136. North America Asthma Preventive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Asthma Preventive Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Asthma Preventive Market Share by Country (2021-2026) Table 139. North America Asthma Preventive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Asthma Preventive Market Share Forecast by Country (2027-2032) Table 141. Europe Asthma Preventive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Asthma Preventive Sales by Country (2021-2026) & (k units) Table 143. Europe Asthma Preventive Sales Market Share by Country (2021-2026) Table 144. Europe Asthma Preventive Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Asthma Preventive Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Asthma Preventive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Asthma Preventive Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Asthma Preventive Market Share by Country (2021-2026) Table 149. Europe Asthma Preventive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Asthma Preventive Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Asthma Preventive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Asthma Preventive Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Asthma Preventive Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Asthma Preventive Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Asthma Preventive Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Asthma Preventive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Asthma Preventive Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Asthma Preventive Market Share by Country (2021-2026) Table 159. Asia-Pacific Asthma Preventive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Asthma Preventive Market Share Forecast by Country (2027-2032) Table 161. Latin America Asthma Preventive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Asthma Preventive Sales by Country (2021-2026) & (k units) Table 163. Latin America Asthma Preventive Sales Market Share by Country (2021-2026) Table 164. Latin America Asthma Preventive Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Asthma Preventive Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Asthma Preventive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Asthma Preventive Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Asthma Preventive Market Share by Country (2021-2026) Table 169. Latin America Asthma Preventive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Asthma Preventive Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Asthma Preventive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Asthma Preventive Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Asthma Preventive Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Asthma Preventive Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Asthma Preventive Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Asthma Preventive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Asthma Preventive Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Asthma Preventive Market Share by Country (2021-2026) Table 179. Middle East and Africa Asthma Preventive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Asthma Preventive Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Asthma Preventive Distributors List Table 184. Asthma Preventive Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Asthma Preventive Image Figure 2. Global Asthma Preventive Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Preventive Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Preventive Sales (2021-2032) & (k units) Figure 5. Sodium Cromolyn Image Figure 6. Global Sodium Cromolyn Sales YoY Growth (2021-2032) & (k units) Figure 7. Prednisolone Image Figure 8. Global Prednisolone Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Asthma Preventive Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Asthma Preventive Market Share by Type 2025 VS 2032 Figure 11. North America Asthma Preventive Sales Market Share in Volume by Type in 2025 Figure 12. North America Asthma Preventive Sales Market Share in Value by Type in 2025 Figure 13. Europe Asthma Preventive Sales Market Share in Volume by Type in 2025 Figure 14. Europe Asthma Preventive Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Asthma Preventive Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Asthma Preventive Sales Market Share in Value by Type in 2025 Figure 17. Latin America Asthma Preventive Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Asthma Preventive Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Asthma Preventive Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Asthma Preventive Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Asthma Preventive Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Asthma Preventive Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Asthma Preventive Market Share by Application 2025 VS 2032 Figure 29. North America Asthma Preventive Sales Market Share in Volume by Application in 2025 Figure 30. North America Asthma Preventive Sales Market Share in Value by Application in 2025 Figure 31. Europe Asthma Preventive Sales Market Share in Volume by Application in 2025 Figure 32. Europe Asthma Preventive Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Asthma Preventive Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Asthma Preventive Sales Market Share in Value by Application in 2025 Figure 35. Latin America Asthma Preventive Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Asthma Preventive Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Asthma Preventive Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Asthma Preventive Sales Market Share in Value by Application in 2025 Figure 39. North America Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Asthma Preventive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Asthma Preventive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Asthma Preventive Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Asthma Preventive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Asthma Preventive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Asthma Preventive Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Asthma Preventive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Asthma Preventive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Asthma Preventive Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Asthma Preventive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Asthma Preventive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Asthma Preventive Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Asthma Preventive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Asthma Preventive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Asthma Preventive Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asthma Preventive Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Asthma Preventive Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Cromolyn
  • Prednisolone
Applications
  • Children
  • Adult
Companies covered
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Astrazeneca
  • Sumitomo Dainippon Pharma
  • Chiesi
  • Boehringer Ingelheim
  • Biotest AG
  • Abbot

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Preventive Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Asthma Preventive Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Asthma Preventive Market by Type
  6. 1.3.1 Sodium Cromolyn
  7. 1.3.2 Prednisolone
  8. 1.4 Global Asthma Preventive Market Size by Type
  9. 1.4.1 Global Asthma Preventive Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Asthma Preventive Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Asthma Preventive Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Asthma Preventive Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Asthma Preventive Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Asthma Preventive Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Asthma Preventive Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Asthma Preventive Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Asthma Preventive Industry Trends
  2. 2.2 Asthma Preventive Industry Drivers
  3. 2.3 Asthma Preventive Industry Opportunities and Challenges
  4. 2.4 Asthma Preventive Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Asthma Preventive Revenue (2021-2026)
  2. 3.2 Global Top Players by Asthma Preventive Sales (2021-2026)
  3. 3.3 Global Top Players by Asthma Preventive Price (2021-2026)
  4. 3.4 Global Asthma Preventive Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Preventive Major Company Production Sites & Headquarters
  6. 3.6 Global Asthma Preventive Company, Product Type & Application
  7. 3.7 Global Asthma Preventive Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Preventive Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Preventive Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Preventive Tier 1, Tier 2, and Tier 3
4 Asthma Preventive Regional Status and Outlook
  1. 4.1 Global Asthma Preventive Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Asthma Preventive Historic Market Size by Region
  3. 4.2.1 Global Asthma Preventive Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Asthma Preventive Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Asthma Preventive Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Asthma Preventive Forecasted Market Size by Region
  7. 4.3.1 Global Asthma Preventive Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Asthma Preventive Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Asthma Preventive Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Asthma Preventive by Application
  1. 5.1 Asthma Preventive Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Asthma Preventive Market Size by Application
  5. 5.2.1 Global Asthma Preventive Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Asthma Preventive Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Asthma Preventive Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Asthma Preventive Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Asthma Preventive Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Asthma Preventive Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Asthma Preventive Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Asthma Preventive Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Asthma Preventive Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Asthma Preventive Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Asthma Preventive Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Asthma Preventive Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GSK
  26. 6.5.1 GSK Company Information
  27. 6.5.2 GSK Business Overview
  28. 6.5.3 GSK Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GSK Asthma Preventive Product Portfolio
  30. 6.5.5 GSK Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Amgen Asthma Preventive Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 Astrazeneca
  38. 6.7.1 Astrazeneca Company Information
  39. 6.7.2 Astrazeneca Business Overview
  40. 6.7.3 Astrazeneca Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astrazeneca Asthma Preventive Product Portfolio
  42. 6.7.5 Astrazeneca Recent Developments
  43. 6.8 Sumitomo Dainippon Pharma
  44. 6.8.1 Sumitomo Dainippon Pharma Company Information
  45. 6.8.2 Sumitomo Dainippon Pharma Business Overview
  46. 6.8.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio
  48. 6.8.5 Sumitomo Dainippon Pharma Recent Developments
  49. 6.9 Chiesi
  50. 6.9.1 Chiesi Company Information
  51. 6.9.2 Chiesi Business Overview
  52. 6.9.3 Chiesi Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chiesi Asthma Preventive Product Portfolio
  54. 6.9.5 Chiesi Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Asthma Preventive Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
  61. 6.11 Biotest AG
  62. 6.11.1 Biotest AG Company Information
  63. 6.11.2 Biotest AG Business Overview
  64. 6.11.3 Biotest AG Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biotest AG Asthma Preventive Product Portfolio
  66. 6.11.5 Biotest AG Recent Developments
  67. 6.12 Abbot
  68. 6.12.1 Abbot Company Information
  69. 6.12.2 Abbot Business Overview
  70. 6.12.3 Abbot Asthma Preventive Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbot Asthma Preventive Product Portfolio
  72. 6.12.5 Abbot Recent Developments
7 North America by Country
  1. 7.1 North America Asthma Preventive Sales by Country
  2. 7.1.1 North America Asthma Preventive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Asthma Preventive Sales by Country (2021-2026)
  4. 7.1.3 North America Asthma Preventive Sales Forecast by Country (2027-2032)
  5. 7.2 North America Asthma Preventive Market Size by Country
  6. 7.2.1 North America Asthma Preventive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Asthma Preventive Market Size by Country (2021-2026)
  8. 7.2.3 North America Asthma Preventive Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Asthma Preventive Sales by Country
  2. 8.1.1 Europe Asthma Preventive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Asthma Preventive Sales by Country (2021-2026)
  4. 8.1.3 Europe Asthma Preventive Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Asthma Preventive Market Size by Country
  6. 8.2.1 Europe Asthma Preventive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Asthma Preventive Market Size by Country (2021-2026)
  8. 8.2.3 Europe Asthma Preventive Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Asthma Preventive Sales by Country
  2. 9.1.1 Asia-Pacific Asthma Preventive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Asthma Preventive Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Asthma Preventive Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Asthma Preventive Market Size by Country
  6. 9.2.1 Asia-Pacific Asthma Preventive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Asthma Preventive Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Asthma Preventive Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Asthma Preventive Sales by Country
  2. 10.1.1 South America Asthma Preventive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Asthma Preventive Sales by Country (2021-2026)
  4. 10.1.3 South America Asthma Preventive Sales Forecast by Country (2027-2032)
  5. 10.2 South America Asthma Preventive Market Size by Country
  6. 10.2.1 South America Asthma Preventive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Asthma Preventive Market Size by Country (2021-2026)
  8. 10.2.3 South America Asthma Preventive Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Asthma Preventive Sales by Country
  2. 11.1.1 Middle East and Africa Asthma Preventive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Asthma Preventive Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Asthma Preventive Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Asthma Preventive Market Size by Country
  6. 11.2.1 Middle East and Africa Asthma Preventive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Asthma Preventive Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Asthma Preventive Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Asthma Preventive Value Chain Analysis
  2. 12.1.1 Asthma Preventive Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Asthma Preventive Production Mode & Process
  7. 12.2 Asthma Preventive Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Asthma Preventive Distributors
  10. 12.2.3 Asthma Preventive Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst